Haugen M, Heier HE, Nissen-Meyer LSH(2026) Is Norway's transfusion service ethical and sustainable? Tidsskr Nor Laegeforen, 146(2) DOI 10.4045/tidsskr.25.0692, PubMed 41670313
Kildal AB, Ueland T, Mirlashari MR, Nissen-Meyer LS, Granerud BK, Dyrhol-Riise AM, Tonby K, Holten AR, Heggelund L, Müller KE, Tveita A, Bøe S, Fagerhol MK, Hetland G, Holter JC, Norwegian SARS-CoV-2 study group(2026) Serial blood serum measurements of calprotectin and deoxyribonuclease in COVID-19 patients during hospitalization and recovery until one year: a prospective, multicenter, observational study BMC Infect Dis, 26(1) DOI 10.1186/s12879-026-12939-x, PubMed 41772481
Søraas A, Engvig A, Alnæs D, Karim LN, Danilova E, Istre MS, Nygaard S, Utgård TR, Ceprnjic S, Reiakvam O, Edvardsen E, Westlye LT, Nygaard AB, Dahl JA, Nissen-Meyer LSH, Ihle-Hansen H, Holland P(2026) Interstitial fluid rejuvenation through young-donor plasma exchange in cognitively impaired patients: a pilot safety and feasibility study Geroscience(in press) DOI 10.1007/s11357-026-02435-0, PubMed 42489967
Get in touch
Contact
Group Leader Lise Sofie Haug Nissen-Meyer Department of immunology and transfusion medicine Tel: +47 +22117828 / 48284525 E-mail: lisoha@ous-hf.no